Showing results 1 to 50 from more than 300,000 results:

Immune Checkpoint Inhibitors: Top KOLs in the world



World Rank Name Topic PersonRank Score help
#1
Matteo ********* ******* (Reveal full name)
Westmead and Blacktown Hospitals, Sydney, NSW, Australia | C
Also Ranks for:
Immune Checkpoint Inhibitors
Ipilimumab Nivolumab
Combination Immunotherapy
Advisory Consultancy
metastatic melanoma
Immune Checkpoint InhibitorsReveal score
#2
Patrick ********* *** (Reveal full name)
Harvard Medical School, Boston, MA, USA | Department of Medi
Also Ranks for:
Advanced Melanoma
Immune Checkpoint Inhibitors
Nivolumab Monotherapy
Antitumor Activity
glembatumumab vedotin
Immune Checkpoint InhibitorsReveal score
#3
Jedd * ******* (Reveal full name)
Human Oncology and Pathogenesis Program, Memorial Sloan Kett
Also Ranks for:
Tumor Immunity
Nivolumab Ipilimumab
Cancer Immunotherapy
Dna Vaccines
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#4
Caroline ****** (Reveal full name)
Gustave Roussy, Villejuif, and Paris-Saclay University, Orsa
Also Ranks for:
Advanced Melanoma
Braf V600
Advisory Consultancy
Immune Checkpoint Inhibitors
monoclonal antibodies
Immune Checkpoint InhibitorsReveal score
#5
Jessica ****** ****** (Reveal full name)
Deutsches Krebsforschungszentrum, Heidelberg, Germany | Depa
Also Ranks for:
Advisory Consultancy
Immune Checkpoint Inhibitors
Early Exanthema
Adjuvant Treatment
metastatic melanoma
Immune Checkpoint InhibitorsReveal score
#6
James * * ****** (Reveal full name)
Royal Marsden NHS Foundation Trust, London, UK | The Royal M
Also Ranks for:
Renal Cell
Advisory Consultancy
Immune Checkpoint Inhibitors
Nivolumab Ipilimumab
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#7
Georgina * **** (Reveal full name)
Department of Medical Oncology, Royal North Shore Hospital,
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Brain Metastases
Braf V600
immune checkpoint inhibitors
Immune Checkpoint InhibitorsReveal score
#8
Frank ******* **** (Reveal full name)
Dana-Farber Cancer Institute, Boston, MA; | Dana Farber Canc
Also Ranks for:
Brain Metastases
Nivolumab Ipilimumab
Solid Tumors
Immune Checkpoint
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#9
Paul * ******* (Reveal full name)
University of Manchester and The Christie NHS Foundation Tru
Also Ranks for:
Lung Cancer
Small Cell
Phase Iii
Immune Checkpoint Inhibitors
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#10
Julie ***** ******* (Reveal full name)
The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Joh
Also Ranks for:
Small Cell
Advanced Nsclc
Clinical Activity
Bristolmyers Squibb
lung cancer
Immune Checkpoint InhibitorsReveal score
#11
Dirk *********** (Reveal full name)
University Hospital Essen, Essen, and German Cancer Consorti
Also Ranks for:
Advisory Consultancy
Braf V600
Grant Funding
Cell Lines
melanoma patients
Immune Checkpoint InhibitorsReveal score
#12
Matthew ***** ******** (Reveal full name)
Memorial Sloan Kettering Cancer Center, New York, NY; | Depa
Also Ranks for:
Lung Cancer
Advanced Nsclc
Acquired Resistance
Small Cell
immune checkpoint blockade
Immune Checkpoint InhibitorsReveal score
#13
Jeffrey * ***** (Reveal full name)
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health
Also Ranks for:
Advisory Consultancy
Complete Resection
Honoraria Grant Funding
Nivolumab Ipilimumab
metastatic melanoma
Immune Checkpoint InhibitorsReveal score
#14
Drew * ******* (Reveal full name)
Bloomberg∼Kimmel Institute for Cancer Immunotherapy and Sidn
Also Ranks for:
Tumor Cells
Prostate Cancer
Inbred Balb Mice
Gene Therapy
mhc class
Immune Checkpoint InhibitorsReveal score
#15
Antoni ***** (Reveal full name)
Division of Hematology and Oncology, UCLA David Geffen Schoo
Also Ranks for:
Dendritic Cells
Braf V600
Advisory Consultancy
Monoclonal Antibodies
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#16
Michael ****** ****** (Reveal full name)
Department of Medicine, Memorial Sloan Kettering Cancer Cent
Also Ranks for:
Nivolumab Ipilimumab
Immune Checkpoint
Monoclonal Antibodies
Radiation Therapy
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#17
Scott ****** ******* (Reveal full name)
Thoracic Oncology Department, H. Lee Moffitt Cancer Center,
Also Ranks for:
Small Cell
Clinical Activity
Advanced Nsclc
Nivolumab Monotherapy
lung cancer
Immune Checkpoint InhibitorsReveal score
#18
Naiyer * ***** (Reveal full name)
Synthekine, Inc., Menlo Park, CA | Herbert Irving Comprehens
Also Ranks for:
Lung Cancer
Small Cell
Advanced Nsclc
Acquired Resistance
local therapy
Immune Checkpoint InhibitorsReveal score
#19
Scott * ********* (Reveal full name)
Department of Medicine (Medical Oncology), Yale School of Me
Also Ranks for:
Lung Cancer
Small Cell
Brain Metastases
Clinical Activity
acquired resistance
Immune Checkpoint InhibitorsReveal score
#20
Janis ***** ***** (Reveal full name)
Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns H
Also Ranks for:
Neoadjuvant Nivolumab
L1 Expression
Lung Cancer
Tumor Cells
merkel cell
Immune Checkpoint InhibitorsReveal score
#21
Jeffrey **** ****** (Reveal full name)
Northwestern University, Chicago, IL | Vanderbilt University
Also Ranks for:
Metastatic Melanoma
Renal Cell
Solid Tumors
Braf Inhibitors
clinical activity
Immune Checkpoint InhibitorsReveal score
#22
Jean‐Charles *********** (Reveal full name)
Drug Development Department (DITEP), Gustave Roussy, 94805,
Also Ranks for:
Small Cell
Advanced Solid Tumors
Adjuvant Chemotherapy
Tumor Carcinoma
lung cancer
Immune Checkpoint InhibitorsReveal score
#23
Padmanee ****** (Reveal full name)
The Immunotherapy Platform, University of Texas MD Anderson
Also Ranks for:
Consultancy Funding
Prostate Cancer
Board Directors
Her2 Expression
honoraria membership
Immune Checkpoint InhibitorsReveal score
#24
Paolo ******* ******** (Reveal full name)
Istituto Nazionale Tumori, IRCCS, Fondazione “G. Pascale", N
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Braf V600
Ipilimumab Patients
phase iii
Immune Checkpoint InhibitorsReveal score
#25
Jean ******* **** (Reveal full name)
Service de Dermatologie et Cancérologie Cutanée, Aix-Marseil
Also Ranks for:
Advisory Consultancy
Advanced Melanoma
Grant Funding
Adjuvant Therapy
travel accommodation expenses
Immune Checkpoint InhibitorsReveal score
#26
Reinhard * ****** (Reveal full name)
Department of Dermatology, University Hospital Zurich, Zuric
Also Ranks for:
Metastatic Melanoma
Cutaneous Lymphomas
Advisory Consultancy
Cell Lymphoma
braf v600
Immune Checkpoint InhibitorsReveal score
#27
Omid * ***** (Reveal full name)
Department of Hematology/Oncology, The Angeles Clinic and Re
Also Ranks for:
Advanced Melanoma
Clinical Activity
Solid Tumors
Ipilimumab Patients
glembatumumab vedotin
Immune Checkpoint InhibitorsReveal score
#28
Suzanne ****** ******** (Reveal full name)
Johns Hopkins Bloomberg/Kimmel Institute for Cancer Immunoth
Also Ranks for:
Advisory Consultancy
Autologous Tumor
Neoadjuvant Nivolumab
Grant Funding
metastatic melanoma
Immune Checkpoint InhibitorsReveal score
#29
Michele **** (Reveal full name)
Center for Immuno-Oncology, University Hospital of Siena and
Also Ranks for:
Metastatic Melanoma
Advisory Consultancy
Honoraria Institution
Hla Class
grant funding
Immune Checkpoint InhibitorsReveal score
#30
Enriqueta ***** (Reveal full name)
Vall d’Hebron University Hospital, Vall d’Hebron Institute o
Also Ranks for:
Advisory Consultancy
Small Cell
Advanced Nsclc
Grant Funding
lung cancer
Immune Checkpoint InhibitorsReveal score
#31
Edward * ***** ***** (Reveal full name)
Department of Medicine, Division of Hematology/Oncology, UCL
Also Ranks for:
Small Cell
Advanced Nsclc
Advisory Consultancy
Honoraria Institution
lung cancer
Immune Checkpoint InhibitorsReveal score
#32
James ******* ******* (Reveal full name)
Department of Immunology, University of Texas MD Anderson Ca
Also Ranks for:
Consultancy Funding
Prostate Cancer
Monoclonal Antigens
Ctla4 Blockade
cell activation
Immune Checkpoint InhibitorsReveal score
#33
Martin **** (Reveal full name)
Department of Thoracic Oncology, Airway Research Center Nort
Also Ranks for:
Small Cell
Advisory Consultancy
Advanced Nsclc
Honoraria Institution
lung cancer
Immune Checkpoint InhibitorsReveal score
#34
Leora **** (Reveal full name)
From Memorial Sloan Kettering Cancer Center, New York (P.K.P
Also Ranks for:
Small Cell
Thymic Carcinomas
Nivolumab Docetaxel
Nccn Guidelines Insights
lung cancer
Immune Checkpoint InhibitorsReveal score
#35
Fabrice ******* (Reveal full name)
Gustave Roussy Cancer Campus, Villejuif, France; | Institut
Also Ranks for:
Advisory Consultancy
Small Cell
Grant Funding Institution
Advanced Nsclc
lung cancer
Immune Checkpoint InhibitorsReveal score
#36
Rene ******** (Reveal full name)
University of Colorado Cancer Center, Aurora, CO | Universit
Also Ranks for:
Ipilimumab Nivolumab
Ras Mutations
Oxygen Supplementation
Mek Inhibition
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#37
Mario ***** (Reveal full name)
Yale School of Medicine, New Haven, Connecticut | Yale Cance
Also Ranks for:
Advanced Melanoma
Clinical Activity
Renal Cell Carcinoma
Solid Tumors
tumor cells
Immune Checkpoint InhibitorsReveal score
#38
Laura * * **** (Reveal full name)
Dell Seton Medical Center at the U. of Texas, Austin, TX, US
Also Ranks for:
Cell Lung
Antitumor Activity
Brain Metastases
Advanced Solid Malignancies
head neck
Immune Checkpoint InhibitorsReveal score
#39
John * * * ****** (Reveal full name)
Netherlands Cancer Institute, Amsterdam, Netherlands; | Anto
Also Ranks for:
Advisory Consultancy
Renal Cell
Grant Funding
Dna Vaccines
advanced melanoma
Immune Checkpoint InhibitorsReveal score
#40
Charles * ***** (Reveal full name)
Molecular Pharmacology Program, Memorial Sloan Kettering Can
Also Ranks for:
Small Cell
Rovalpituzumab Tesirine
Solid Tumors
Neuroendocrine Carcinoma
lung cancer
Immune Checkpoint InhibitorsReveal score
#41
Vanna *************** (Reveal full name)
Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRC
Also Ranks for:
Advanced Melanoma
Advisory Consultancy
Honoraria Grant Funding
Dabrafenib Trametinib
3 trial
Immune Checkpoint InhibitorsReveal score
#42
Piotr ********* (Reveal full name)
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria S
Also Ranks for:
Metastatic Melanoma
Gastrointestinal Stromal
Retroperitoneal Sarcoma
Phase Iii
adjuvant imatinib
Immune Checkpoint InhibitorsReveal score
#43
Christopher * ******** (Reveal full name)
Bristol Myers Squibb, Princeton, New Jersey. | Bristol-Myers
Also Ranks for:
Therascreen Assay
Cell Lung
Nivolumab Monotherapy
Ipilimumab Patients
disease control
Immune Checkpoint InhibitorsReveal score
#44
David * ********* (Reveal full name)
Division of Medical Oncology, Beth Israel Deaconess Medical
Also Ranks for:
Epidermodysplasia Verruciformis
Nivolumab Everolimus
X4 Pharmaceuticals
Consultancy Funding
renal cell
Immune Checkpoint InhibitorsReveal score
#45
Gregory * ********** (Reveal full name)
Global Clinical Development, Merck Sharp & Dohme Corp., a su
Also Ranks for:
Advanced Nsclc
Grant Funding Institution
Cell Lung
Pembrolizumab Docetaxel
advisory consultancy
Immune Checkpoint InhibitorsReveal score
#46
Robert ****** ****** (Reveal full name)
Department of Oncology, Johns Hopkins University School of M
Also Ranks for:
Liver Regeneration
Pancreatic Cancer
Pdl1 Expression
Microvascular Invasion
hepatocellular carcinoma
Immune Checkpoint InhibitorsReveal score
#47
Charles * ***** (Reveal full name)
Division of Hematology Oncology, Columbia University Irving
Also Ranks for:
Immune Response
Tumor Microenvironment
Clinical Activity
Renal Cell
prostate cancer
Immune Checkpoint InhibitorsReveal score
#48
Hossein ******** (Reveal full name)
Department of Hematology and Oncology, Fox Chase Cancer Cent
Also Ranks for:
Lung Cancer
Small Cell
Amg 757
Advanced Nsclc
bristolmyers squibb
Immune Checkpoint InhibitorsReveal score
#49
John ******** (Reveal full name)
The College of Medicine, Swansea University, Swansea, United
Also Ranks for:
Advanced Melanoma
Advisory Consultancy
Septic Shock
Grant Funding Honoraria
renal cell
Immune Checkpoint InhibitorsReveal score
#50
Luis * ******** (Reveal full name)
Medical Oncology, Hospital Universitario 12 de Octubre, CNIO
Also Ranks for:
Small Cell
Advanced Nsclc
Phase Iii
Bristolmyers Squibb
lung cancer
Immune Checkpoint InhibitorsReveal score